Head To Head Hot StocksLoews Corporation (NYSE:L), Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)

Loews Corporation (NYSE:L)

Loews Corporation (NYSE:L) closed at $47.89 on the last trading session with an increase of 0.38%, whereas, it previously closed at $47.71. The company has a market capitalization of $14.89 Billion. The company traded shares of 917878 on the trading day while its three month average volume stands at 1.2 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Loews Corporation (NYSE:L) produced diluted EPS of 1.96. The EPS estimate for next year as estimated by analysts is at 3.5 while EPS for next quarter is estimated at 0.95. Earnings per Share growth for this year is reported at -31.1, while the analysts estimated the EPS growth for next year at 3.5% and Earnings growth for next 5 years stands at 20.68% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -7.6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Loews Corporation (NYSE:L) is at 24.41 while the forward p/e is at 13.68. The P/S or Price to Sales ratio of Loews Corporation (NYSE:L) stands at 1.06 and Price to Book or P/B for the most recent quarter stands at 0.81. The Price to Free Cash Flow ratio or P/FCF is reported at 4.73. The quick ratio and the current ratio of Loews Corporation (NYSE:L) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Loews Corporation (NYSE:L) stands at 0.8, 3.4 and 4.3 respectively

The trailing twelve month Revenue of Loews Corporation (NYSE:L) is reported at 14.09 Billion with income of 636 Million. The outstanding shares of Loews Corporation (NYSE:L) are 310.9 Million. The institutional Ownership of the shares of 67 stands at 0.80%, this figure is decreased -2.13 in the last six months. The insider ownership for the shares of Loews Corporation (NYSE:L) is ticked at 69.71%, the figure is plummeted -0.03% in the last six months.

Some other important financial aspects to be discussed here for Loews Corporation (NYSE:L) is the Mean Target Price estimated by the analysts which stands at 54. The 52 week high of Loews Corporation (NYSE:L) is placed at 53.04 and 52 week low is standing at 42.06.

Performance wise the shares of Loews Corporation (NYSE:L) rose up 2.29% for the week, it also rise 4.29% for the monthly performance, while for the quarter it went down 6.75%. The shares decrease -4.43% for the half year and flew up for the Year-To-Date performance. The shares of Loews Corporation (NYSE:L) shrinked -6.54% for the yearly performance.

Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX)

Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) closed at $4.03 on the last trading session with an decrease of -1.71%, whereas, it previously closed at $4.1. The company has a market capitalization of $201.06 Million. The company traded shares of 387417 on the trading day while its three month average volume stands at 423.53 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) produced diluted EPS of -1.79. The EPS estimate for next year as estimated by analysts is at -1.39 while EPS for next quarter is estimated at -0.3. Earnings per Share growth for this year is reported at 3.4, while the analysts estimated the EPS growth for next year at -1.39% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at 0%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) stands at 55.85 and Price to Book or P/B for the most recent quarter stands at 2.4. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) are reported at 9.7 and 9.7 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) stands at -88.4, -103.9 and -81.5 respectively

The trailing twelve month Revenue of Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) is reported at 3.6 Million with income of -74200000. The outstanding shares of Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) are 49.89 Million. The institutional Ownership of the shares of 64.7 stands at 0.80%, this figure is decreased -2.55 in the last six months. The insider ownership for the shares of Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) is ticked at 1.3%, the figure is rose 21.2% in the last six months.

Some other important financial aspects to be discussed here for Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) is the Mean Target Price estimated by the analysts which stands at 15.5. The 52 week high of Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) is placed at 7.60 and 52 week low is standing at 3.21.

Performance wise the shares of Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) rose up 0.75% for the week, it also rise 13.52% for the monthly performance, while for the quarter it went down 5.77%. The shares decrease -31.93% for the half year and flew up for the Year-To-Date performance. The shares of Foamix Pharmaceuticals Ltd. (NASDAQ:FOMX) shrinked -28.29% for the yearly performance.